- €3.45bn
- €4.02bn
- €1.20bn
Europe's STOXX 600 closes higher, focus shifts to Nvidia results (updated)
Top of the Street: Deutsche Bank, Commerzbank, UniCredit
JPM starts DiaSorin at 'underweight' on limited scope for margin progress
Europe Research Roundup: Bioinvent, Diasorin, Sandoz
JPM starts bioMérieux at 'neutral', says growth prospects priced in
Morgan Stanley ups DiaSorin to 'overweight' on 'rare opportunity' valuation, shares rise
Europe Research Roundup: Barclays, Kingfisher, Tesco
Lottomatica seen joining Italy's blue chip stock index, ousting Diasorin or Pirelli
'Buying opportunity ahead of growth acceleration' - RBC raises DiaSorin to 'outperform'
Europe Research Roundup: Diasorin, Kingspan Group, Nexans
Europe Research Roundup: Accor, Danone, Enel
Brief: Diasorin to close German factory and moving production to Italy by 2026, CEO says
Brief: Diasorin Q2 Adj. EBITDA EUR 107 Mln
Italy - Factors to watch on July 31
Brief: Diasorin Receives 510(K) Authorization From U.S. FDA For Liaison Plex Gram-Positive Blood Culture Assay
Europe Research Roundup: EasyJet, Gerresheimer, Johnson Matthey
Italy - Factors to watch on May 19
Factbox: China exempts some US imports from tariffs
Europe Research Roundup: Deliveroo, Endesa, Natwest Group